More Company News

Avacta

AffyXell JV milestone and increased equity stake
13 Apr 2022Read More

Avacta

AVA6000 poster presented at AACR
12 Apr 2022Read More

Avacta

AffyXell JV partners with Biocytogen and KNTSC
08 Apr 2022Read More

Avacta

Preliminary FY21 results
06 Apr 2022Read More

Avacta

AVA6000 preclinical data to be presented at AACR
29 Mar 2022Read More

Avacta

Vimian acquires Avacta’s Animal Health Division
16 Mar 2022Read More

Avacta

Dose escalation in AVA6000 Phase I study
03 Feb 2022Read More

Avacta

Second pre|CISION pro-drug candidate selected
18 Jan 2022Read More

Avacta

Update on AffiDX and detection of Omicron variant
10 Jan 2022Read More

Avacta

AffiDX LFT receives CE Mark for consumer self-testing
22 Dec 2021Read More

1 2 3
Return to Avacta
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).